Snail-based oral medical device for cough relief – already approved in Morocco
Entering new markets is easier with an experienced partner
Entering a new market quickly is easier when you rely on someone who has already paved the way. Thanks to our direct experience with the registration of this specific product in Morocco, we can offer fast access with no bureaucratic obstacles.
Being already registered in Morocco is a strategic asset: it means we thoroughly understand local authority requirements, have completed every regulatory phase, and can now offer this expertise to those aiming to export compliant, approved products.
We offer a full range of ready-to-market products — also available in private label — and a comprehensive third-party manufacturing service for medical devices, food supplements, and cosmetics. Our approach is designed to simplify access to international markets.
Thanks to our consolidated regulatory know-how, we support clients through every phase of the approval process: from formulation adaptation to the preparation of technical documentation, all the way to obtaining marketing authorizations in the target country.
An effective, natural oral medical device for cough – already approved in Morocco
Our flagship product? An oral medical device for cough based on snail secretion filtrate, already been approved by the Moroccan authorities. Designed to act on the main symptoms of both dry and productive cough, it offers a modern, safe, and effective solution for fast and long-lasting relief.
Indicated for:
- Dry cough
- Chronic cough
- Reflux-induced cough
- Throat itching
- Oropharyngeal mucosal irritation
The formulation is based on a patented synergistic complex — an exclusive mix of:
- Snail secretion filtrate
- Low and high molecular weight hyaluronic acid
- Cyclodextrins
This combination forms a protective, barrier-effect film capable of soothing cough, hydrating mucous membranes, and protecting the upper respiratory tract.
A mucoadhesive, natural formula for both adults and children
What sets this product apart is its ability to adhere to mucosal surfaces, offering prolonged action. Thanks to the presence of dual-weight hyaluronic acid, it works on multiple levels: immediate symptom relief and long-term mucosal protection.
The formula is further enriched with:
- Iceland moss (dry extract)
- Sodium alginate
- Eucalyptus essential oil
- Thyme essential oil
These natural ingredients enhance the device’s action by aiding mucus removal, soothing irritation, and supporting the throat’s natural function. Free from side effects, it is also suitable for pediatric use.
Already registered: an immediate competitive advantage
The fact that our oral medical device is already registered in Morocco allows our partners to:
- Accelerate commercial market entry
- Avoid lengthy documentation processes
- Collaborate with a partner who has already completed (and passed) the entire regulatory pathway
Being approved in a target country is a high-value commercial and strategic asset — especially in the medical device sector, where regulatory timelines can significantly impact business plans.
Our goal is to make international market entry fast, secure, and compliant, leveraging our concrete, hands-on experience.
A functional and natural approach to cough relief
Cough — whether dry or productive — is among the most common and often most disruptive conditions, especially during the winter or in polluted environments. Our approach combines natural active ingredients with mucoadhesive technology to deliver effective treatment without suppressing the cough reflex — instead, protecting and restoring the mucosa.
This makes our snail-based medical device ideal for:
- Patients with chronic or irritative cough
- Children sensitive to standard pharmaceutical formulations
- Individuals with reflux-related symptoms or chronic mucosal dryness
- Use alongside other therapeutic treatments
Contact us to find out how we can support your success in your target market. With our experience, you enter quickly, without obstacles, and with a solution ready for commercialization.
